News about "CNS therapies"

Mankind Pharma Acquires Rivotril Brand for India, Reinforcing Focus on Chronic CNS Therapies

Mankind Pharma Acquires Rivotril Brand for India, Reinforcing Focus on Chronic CNS Therapies

Mankind Pharma Limited today announced that it has acquired the brand Rivotril from Roche for the Indian market, with exclusive rights to manufacture, market and distribute the product across the country. Rivotril is the innovator/ reference brand of clonazepam and is widely prescribed for the management of neurological and psychiatric conditions.

CNS Therapies | 19/03/2026 | By Darshana


 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members